Drug Type Small molecule drug |
Synonyms Oxycodone/alexopran, Oxycodone/TD-1211, TD-1211/oxycodone |
Target |
Action antagonists |
Mechanism μ opioid receptor antagonists(Mu opioid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H39N3O4 |
InChIKeyATLYLVPZNWDJBW-KIHHCIJBSA-N |
CAS Registry949904-48-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Constipation | Phase 2 | Australia | - | |
| Pain | Phase 2 | Australia | - |





